Pharmacotherapy of dementia in Germany: Results from a nationwide claims database.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  European Neuropsychopharmacology

• Publication date

  2015-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.euroneuro.2015.09.014PMID 26476703
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.

  2015cited by this paper
• Antidementia Drug Treatment in People Screened Positive for Dementia in Primary Care

  2015cited by this paper
• Continuous treatment with antidementia drugs in Germany 2003–2013: a retrospective database analysis

  2015cited by this paper
• SveDem, the Swedish Dementia Registry – A Tool for Improving the Quality of Diagnostics, Treatment and Care of Dementia Patients in Clinical Practice

  2015cited by this paper
• Antipsychotic Drug Treatment in Ambulatory Dementia Care: Prevalence and Correlates

  2014cited by this paper
• P3‐362: DEMENTIA AND LONG‐TERM CARE: AN ANALYSIS BASED ON GERMAN HEALTH INSURANCE DATA

  2014cited by this paper
• Efficacy and Adverse Effects of Ginkgo Biloba for Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Anti-Dementia Drugs and Co-Medication Among Patients with Alzheimer’s Disease

  2014cited by this paper
• Impact of safety warnings on antipsychotic prescriptions in dementia: nothing has changed but the years and the substances.

  2013cited by this paper
• Diagnosestellung und Diagnosecodierung von Demenzen im Spiegel der Abrechnungsdaten der gesetzlichen Krankenversicherung

  2013cited by this paper
• [Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)].

  2012cited by this paper
• Antipsychotic Drugs Predominate in Pharmacotherapy of Nursing Home Residents with Dementia

  2012cited by this paper
• Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland

  2011cited by this paper
• Trends in antipsychotic use in dementia 1999-2007.

  2011cited by this paper
• [Prescription differences of dementia drugs in urban and rural areas in Germany].

  2011cited by this paper
• Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up

  2011cited by this paper
• The pharmacotherapy of neuropsychiatric symptoms of dementia: a cross-sectional study in 18 homes for the elderly in Berlin.

  2010cited by this paper
• Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany

  2010cited by this paper
• The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial.

  2009cited by this paper
• Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline

  2007cited by this paper
• Prevalence and correlates of disruptive behavior in patients in Norwegian nursing homes

  2007cited by this paper
• Donepezil for dementia due to Alzheimer's disease.

  2006cited by this paper
• Effects of Cholinesterase Inhibitors on Behavioural Disturbances in Alzheimer’s Disease

  2006cited by this paper
• Factors associated with depression in a representative sample of 14 217 people aged 75 and over in the United Kingdom: results from the MRC trial of assessment and management of older people in the community

  2003cited by this paper

• Urban-rural differences in the health care of people living with dementia and mild cognitive impairment in shared-housing arrangements in Germany – have inequities in urban vs. rural locations been overcome?

  2025influential citation
• Dementia diagnosis and prescription of antidementia drugs: An analysis of German claims data (2006–2016)

  2025cites this paper
• Rural–Urban Differences in Healthcare Use in Persons With Dementia Between 2000 and 2019: A Quebec Population-Based Study

  2024cites this paper
• Rural and urban differences in quality of dementia care of persons with dementia and caregivers across all domains: a systematic review

  2023influential citation
• Dementia in health claims data: The influence of different case definitions on incidence and prevalence estimates

  2022cites this paper
• Antidepressant drug use and regional prescribing patterns in Germany: results from a large population-based study

  2022cites this paper
• Trends in Dementia and Mild Cognitive Impairment Prevalence and Incidence in German General and Specialist Practices Between 2015 and 2019

  2021cites this paper
• Dementia care and the role of guideline adherence in primary care: cross-sectional findings from the DemTab study

  2021cites this paper
• Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China.

  2021cites this paper
• Komplexbehandlung bei schweren psychischen Erkrankungen im Alter – eine Positionsbestimmung

  2021cites this paper
• Treatment Patterns of Patients with All-Cause Dementia in Russia

  2020cites this paper
• Potenziale und Grenzen von Alternskohortenstudien für die Gerontopsychiatrie

  2020cites this paper
• Remote patient monitoring using artificial intelligence

  2020cites this paper
• Health-Care Delivery for Older People with Dementia in Primary Care

  2019cites this paper
• Die Versorgung für die nächste Dekade sichern: Gerontopsychiatrie in der Krise?

  2019cites this paper
• Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia

  2019cites this paper
• What is happening with not recommended drugs for dementia in Argentina? Prescription patterns and direct costs analysis

  2019cites this paper
• Effekt der ambulanten geriatrischen Komplexbehandlung auf Polypharmazie und potenziell inadäquate Arzneimittel – eine Beobachtungsstudie

  2019cites this paper
• Predictors of high hospital care and medication costs and cost trajectories in community-dwellers with Alzheimer’s disease

  2019cites this paper
• [Incidence and treatment of non-substance-induced delirium in general and specialist practices in Germany].

  2018cites this paper
• Alzheimer-Demenz: Verlauf und Belastung der Pflegepersonen

  2018cites this paper
• [Diagnostic and Prescription Behavior of General Practitioners and Specialist Physicians in Patients with Dementia in 2005 and 2015 in Germany].

  2018influential citation
• Antidementia drug use in Japan: Bridging the research‐to‐practice gap

  2018cites this paper
• Antipsychotic treatment of community-dwelling and institutionalised patients with dementia in Germany

  2018cites this paper
• The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany

  2018cites this paper
• Diagnose- und Verordnungsverhalten von Haus- und Fachärzten bei Patienten mit Demenz 2005 und 2015 in Deutschland

  2017influential citation
• [Implementation of the German S3 guidelines on dementia in clinical practice: wish or reality?]

  2017cites this paper
• [The Influence of Caseload on Continuous Treatment with Antidementia Drugs].

  2017cites this paper
• [High Prevalence of Antipsychotic Medication Use in Dementia Patients in German Neuropsychiatric Practices].

  2017cites this paper
• Polypharmacy in Nursing Home Residents with Dementia

  2017cites this paper
• Prescription patterns and drug costs in German patients with dementia in nursing homes and home-care settings
.

  2017cites this paper
• Use of antidementia drugs in German patients with Alzheimer’s disease

  2017cites this paper
• Psychopharmakotherapie bei Demenz und Delir

  2017cites this paper
• Can volunteering in later life reduce the risk of dementia? A 5-year longitudinal study among volunteering and non-volunteering retired seniors

  2017cites this paper
• Umsetzung der S3-Leitlinie „Demenzen“ im klinischen Alltag: Wunsch oder Wirklichkeit?

  2017cites this paper
• Geben Ärzte bei Demenz zu oft Antipsychotika?

  2016cites this paper
• Bei Demenz werden weiterhin erstaunlich oft Antipsychotika verordnet

  2016cites this paper
• Warum und auf wessen Initiative werden Antidementiva in der nachstationären ambulanten Behandlung der Demenz abgesetzt

  2016cites this paper
• Mental and Social Health Atlas: An Update, Ministry of Health, Saudi Arabia, 2015

  2016cites this paper
• Chronic sleep disturbance and neural injury: links to neurodegenerative disease

  2016cites this paper
• Persistence with antipsychotics in dementia patients in Germany
.

  2016cites this paper
• [Are physicians treating dementia too often with antipsychotics?].

  2016cites this paper